Medtronic (MDT) Tops Q1 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
Medtronic (NYSE: MDT) reported Q1 EPS of $1.26, $0.03 better than the analyst estimate of $1.23. Revenue for the quarter came in at $8.6 billion versus the consensus estimate of $8.38 billion.
GUIDANCE:
Medtronic sees FY2026 EPS of $5.60-$5.66, versus the consensus of $5.55.
For earnings history and earnings-related data on Medtronic (MDT) click here.